These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16796899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
    Chen CH, Shu KH, Wen MC, Chen KJ, Cheng CH, Lian JD, Wu MJ, Yu TM, Tsai FJ.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
    [Abstract] [Full Text] [Related]

  • 3. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 4. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ, Xue YM, Yang GC, He FY, Zhao XS.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [Abstract] [Full Text] [Related]

  • 9. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

  • 10. [The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].
    Zhang C, Li J, Li L, Luo B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):383-7. PubMed ID: 11592048
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Oct; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 12. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R, Liu Z, Chen Z, Li L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
    Schenk JF, Stephan B, Zewinger S, Speer T, Pindur G.
    Clin Hemorheol Microcirc; 2008 Feb; 39(1-4):329-32. PubMed ID: 18503142
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Relationship between PAI-1 gene 4G/5G polymorphism and clinical profile of IgA nephropathy].
    Ding R, Chen XM, Liu SW, Lv Y, Wu J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):449-51. PubMed ID: 16883539
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Aug; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.